Effective leadership can have a positive impact on physician satisfaction.
Editor's note: If you are struggling with your mental health right now, you are not alone. Please take advantage of APMA's physician well-being resources.
Sceptre fights for your right to reimbursement. Payers like denying clean claims. Sceptre has the knowledge, skills and ability to get your claims paid faster. We will help reduce your receivables by resolving claims quickly and capturing the full reimbursement. Partner with us by calling Jennifer Hicks at 801-775-8010; partnerwithus@sceptremanagement.com
Total Ancillary provides multiple skin substitute products in one vendor, a revolutionary software portal to manage the process, and world-class customer service. Providers using Total Ancillary for biologics (1) Have More Covered Product Options to offer their patients, (2) Treat More Patients More Confidently, and (3) Promote Superior Clinical Outcomes versus traditional wound care.
According to a new survey, patients who had had a negative experience with a health-care provider were more likely to avoid seeking needed care in the future.
Talar Medical is a group purchasing organization that houses 31 of the best vendors in Podiatric medicine to bring you discounted pricing in one easy to use portal. Working with some of the best minds in the Podiatric space, Talar is a place that teaches physicians and staff how to implement the best products and protocols into practice. Our membership is free, and you can receive a free cost analysis!
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
Government health officials announced that booster shots will be offered to Americans who are eight months past the date of their second vaccination with either the Pfizer or Moderna vaccine. A decision on boosters for the Johnson & Johnson vaccine has not yet been made.
